Find Clinical Trials
Study assessing the glucose-lowering efficacy and safety of luseogliflozin on top of metformin in Caucasian patients with type 2 diabetes mellitus
Servier Protocol Code:
CL3-LUSEO-001
Sponsor:
JSC Servier (Russia)
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Interventions / Treatments
The treatment(s) given to the participants in the study.
- Diabetes - Type II
- Luseogliflozin
Other study id numbers
Other identification numbers the study may be known by.
- CL3-LUSEO-001